Consort Medical (CSRMY) Cut to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of Consort Medical (OTCMKTS:CSRMY) from a buy rating to a hold rating in a research note issued to investors on Tuesday.

According to Zacks, “Consort Medical Plc engages in the design, development, manufacture and sale of medical drug delivery devices. It operates through the Bespak and Aesica segments. Bespak segment develops and produces drug delivery devices which serves pharmaceutical companies with inhaler and auto-injector technologies. Aesica segment is a contract development and manufacturing organization which serves pharmaceutical firms with active pharmaceutical ingredient and finished dose formulation development and manufacturing services. Consort Medical Plc is headquartered in Hemel Hempstead, United Kingdom. “

Consort Medical (OTCMKTS:CSRMY) opened at $16.00 on Tuesday. Consort Medical has a 52-week low of $13.00 and a 52-week high of $16.00.

The business also recently announced a None dividend, which will be paid on Monday, February 26th. Investors of record on Friday, January 19th will be given a dividend of $0.087 per share. The ex-dividend date is Thursday, January 18th.

TRADEMARK VIOLATION WARNING: “Consort Medical (CSRMY) Cut to Hold at Zacks Investment Research” was first published by Markets Daily and is owned by of Markets Daily. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at

About Consort Medical

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.

Get a free copy of the Zacks research report on Consort Medical (CSRMY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply